Scarica l'app Stockscreener
0.9419
7.66%
-0.0781
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.02
Aprire:
$0.9996
Volume 24 ore:
316.88K
Relative Volume:
0.10
Capitalizzazione di mercato:
$6.40M
Reddito:
-
Utile/perdita netta:
$-1.13M
Rapporto P/E:
-2.0516
EPS:
-0.4591
Flusso di cassa netto:
$-4.60M
1 W Prestazione:
-18.10%
1M Prestazione:
+19.68%
6M Prestazione:
-6.74%
1 anno Prestazione:
-45.24%
Intervallo 1D:
$0.9321
$1.05
Intervallo di 1 settimana:
$0.9321
$1.20
Portata 52W:
$0.63
$1.90
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Nome
Pharmacyte Biotech Inc
Settore
Industria
Telefono
(917) 595.2850
Indirizzo
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Confronta PMCB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.17 | 303.77M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.04 | 221.34M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.67 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.76 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Borsa (PMCB) Ultime notizie
PharmaCyte Biotech Delays Quarterly Report Filing - TipRanks
Largest borrow rate increases among liquid names - TipRanks
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PharmaCyte Biotech faces NASDAQ non-compliance notice - MSN
Healthy Upside Potential: PharmaCyte Biotech Inc (PMCB) - setenews.com
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice - TipRanks
PharmaCyte Biotech’s Potential Explored Amidst Market Movements - timothysykes.com
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
Why PharmaCyte Biotech Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Down 6.1% – Here’s What Happened - Defense World
Take off with PharmaCyte Biotech Inc (PMCB): Get ready for trading - Setenews
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Is PharmaCyte Biotech Inc a good long term investmentVolatility Adjusted Trading & High Profit Market Ideas - earlytimes.in
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech - The Pharma Letter
PharmaCyte Biotech successfully monetizes Femasys stake - The Pharma Letter
Check Out PharmaCyte Biotech Inc (PMCB)’s Trade Data Rather Than the Analysts’ Views - Setenews
A History of Outperforming Analyst Forecasts and Beating the Odds: Clean Energy Technologies Inc (CETY) - Setenews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
PharmaCyte Biotech (PMCB) Stock: Increases Cash and Securities to $20M Strengthening Balance Sheet - parameter.io
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech, Inc. (PMCB) 17.97% in Intraday Trading: Success in Monetization Bolsters Financial Position - Stocks Telegraph
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million By Investing.com - Investing.com South Africa
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Pancreatic Cancer Precision Medicine Market Size to Hit USD 4,030.16 Mn by 2034 - Precedence Research
PharmaCyte Biotech Amends Equity Incentive Plan - MSN
Is Simplify Health Care ETF stock good for wealth creationMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Nuvilex (NASDAQ:PMCB) Shares Down 3% – Should You Sell? - Defense World
Is PharmaCyte Biotech Inc. forming a bottoming baseJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Combining machine learning predictions for PharmaCyte Biotech Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Statistical indicators supporting PharmaCyte Biotech Inc.’s strength2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
[8-K/A] PharmaCyte Biotech, Inc. Amends Material Event Report | PMCB SEC FilingForm 8-K/A - Stock Titan
What sentiment indicators say about PharmaCyte Biotech Inc. stock2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
What Fibonacci levels say about PharmaCyte Biotech Inc. rebound2025 Winners & Losers & Long-Term Growth Plans - newser.com
Applying chart zones and confluence areas to PharmaCyte Biotech Inc.Weekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
Pharmacyte Biotech Inc Azioni (PMCB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):